Our latest deals : Domain Therapeutics ($42M series A), Ludocare (€4.2M Seed), Spine Innovations (M&A sell-side, un-disclosed amount), Neurofenix ($7M series A), Incepto (€27M series B)
Menu
About us
Agile Capital Markets is an investment banking boutique dedicated to life sciences companies
We offer special capabilities to address the critical issue of financing innovation in the healthcare arena. Agile Capital Markets has built a proven track record in raising funds, building strategies and structuring partnerships with a focus on value creation.
Agile Capital Markets stands out as a partner for funds and entrepreneurs in the field of healthcare and life sciences, seeking more than advisory and looking for strategic support and orientations while focusing on their businesses.
Fundraising and growth financing
Tap into our network of investors to finance your life sciences company at every development stage. Agile Capital Markets has a proven expertise in raising capital in various forms and through innovative solutions (from 3 M€ to 60 M€, series A to C+).
Early-stage financing
Debt & equity, both public and private
IPOs
Secondary offerings
M&A advisory
We provide high level and strong support on transactions, and execution of cross-border transactions.
Defining exit strategies
Fine-tuning valuation analysis
Identifying acquisition targets
Managing spin-out activities
Business Development & strategic partnerships
Our background as life science company executives gives us a unique edge in assisting companies in developing their businesses. Thanks to our international reach, we build up their partnership strategies with key players within the industry and bring value in their licensing process.
We leverage our expertise with a network of leading executives and industry experts to build your strategy in every aspect, scientific, medical, operational, legal and financial.
